These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 28606939)

  • 1. Transcriptional and epigenetic regulation of T cell hyporesponsiveness.
    Pereira RM; Hogan PG; Rao A; Martinez GJ
    J Leukoc Biol; 2017 Sep; 102(3):601-615. PubMed ID: 28606939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptional and Epigenetic Regulation of Effector and Memory CD8 T Cell Differentiation.
    Chen Y; Zander R; Khatun A; Schauder DM; Cui W
    Front Immunol; 2018; 9():2826. PubMed ID: 30581433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcription factor regulation of CD8+ T-cell memory and exhaustion.
    Angelosanto JM; Wherry EJ
    Immunol Rev; 2010 Jul; 236():167-75. PubMed ID: 20636816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterogeneity and fate choice: T cell exhaustion in cancer and chronic infections.
    Philip M; Schietinger A
    Curr Opin Immunol; 2019 Jun; 58():98-103. PubMed ID: 31181510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromatin states define tumour-specific T cell dysfunction and reprogramming.
    Philip M; Fairchild L; Sun L; Horste EL; Camara S; Shakiba M; Scott AC; Viale A; Lauer P; Merghoub T; Hellmann MD; Wolchok JD; Leslie CS; Schietinger A
    Nature; 2017 May; 545(7655):452-456. PubMed ID: 28514453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Developmental Relationships of Four Exhausted CD8
    Beltra JC; Manne S; Abdel-Hakeem MS; Kurachi M; Giles JR; Chen Z; Casella V; Ngiow SF; Khan O; Huang YJ; Yan P; Nzingha K; Xu W; Amaravadi RK; Xu X; Karakousis GC; Mitchell TC; Schuchter LM; Huang AC; Wherry EJ
    Immunity; 2020 May; 52(5):825-841.e8. PubMed ID: 32396847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TOX is a critical regulator of tumour-specific T cell differentiation.
    Scott AC; Dündar F; Zumbo P; Chandran SS; Klebanoff CA; Shakiba M; Trivedi P; Menocal L; Appleby H; Camara S; Zamarin D; Walther T; Snyder A; Femia MR; Comen EA; Wen HY; Hellmann MD; Anandasabapathy N; Liu Y; Altorki NK; Lauer P; Levy O; Glickman MS; Kaye J; Betel D; Philip M; Schietinger A
    Nature; 2019 Jul; 571(7764):270-274. PubMed ID: 31207604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stem, Effector, and Hybrid States of Memory CD8
    Lugli E; Galletti G; Boi SK; Youngblood BA
    Trends Immunol; 2020 Jan; 41(1):17-28. PubMed ID: 31810790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exhaustion-associated regulatory regions in CD8
    Mognol GP; Spreafico R; Wong V; Scott-Browne JP; Togher S; Hoffmann A; Hogan PG; Rao A; Trifari S
    Proc Natl Acad Sci U S A; 2017 Mar; 114(13):E2776-E2785. PubMed ID: 28283662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Running to Stand Still: Naive CD8
    Bennett TJ; Udupa VAV; Turner SJ
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33371448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcription Factor IRF4 Promotes CD8
    Man K; Gabriel SS; Liao Y; Gloury R; Preston S; Henstridge DC; Pellegrini M; Zehn D; Berberich-Siebelt F; Febbraio MA; Shi W; Kallies A
    Immunity; 2017 Dec; 47(6):1129-1141.e5. PubMed ID: 29246443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extended co-expression of inhibitory receptors by human CD8 T-cells depending on differentiation, antigen-specificity and anatomical localization.
    Baitsch L; Legat A; Barba L; Fuertes Marraco SA; Rivals JP; Baumgaertner P; Christiansen-Jucht C; Bouzourene H; Rimoldi D; Pircher H; Rufer N; Matter M; Michielin O; Speiser DE
    PLoS One; 2012; 7(2):e30852. PubMed ID: 22347406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generating long-lived CD8(+) T-cell memory: Insights from epigenetic programs.
    Dogra P; Ghoneim HE; Abdelsamed HA; Youngblood B
    Eur J Immunol; 2016 Jul; 46(7):1548-62. PubMed ID: 27230488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD8
    Dolina JS; Van Braeckel-Budimir N; Thomas GD; Salek-Ardakani S
    Front Immunol; 2021; 12():715234. PubMed ID: 34354714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Premature terminal exhaustion of Friend virus-specific effector CD8+ T cells by rapid induction of multiple inhibitory receptors.
    Takamura S; Tsuji-Kawahara S; Yagita H; Akiba H; Sakamoto M; Chikaishi T; Kato M; Miyazawa M
    J Immunol; 2010 May; 184(9):4696-707. PubMed ID: 20351188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic stability of exhausted T cells limits durability of reinvigoration by PD-1 blockade.
    Pauken KE; Sammons MA; Odorizzi PM; Manne S; Godec J; Khan O; Drake AM; Chen Z; Sen DR; Kurachi M; Barnitz RA; Bartman C; Bengsch B; Huang AC; Schenkel JM; Vahedi G; Haining WN; Berger SL; Wherry EJ
    Science; 2016 Dec; 354(6316):1160-1165. PubMed ID: 27789795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination OX40 agonism/CTLA-4 blockade with HER2 vaccination reverses T-cell anergy and promotes survival in tumor-bearing mice.
    Linch SN; Kasiewicz MJ; McNamara MJ; Hilgart-Martiszus IF; Farhad M; Redmond WL
    Proc Natl Acad Sci U S A; 2016 Jan; 113(3):E319-27. PubMed ID: 26729864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD8 T Cell Exhaustion During Chronic Viral Infection and Cancer.
    McLane LM; Abdel-Hakeem MS; Wherry EJ
    Annu Rev Immunol; 2019 Apr; 37():457-495. PubMed ID: 30676822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Demethylation of the PD-1 Promoter Is Imprinted during the Effector Phase of CD8 T Cell Exhaustion.
    Ahn E; Youngblood B; Lee J; Lee J; Sarkar S; Ahmed R
    J Virol; 2016 Oct; 90(19):8934-46. PubMed ID: 27466420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting PD-1 and Tim-3 Pathways to Reverse CD8 T-Cell Exhaustion and Enhance Ex Vivo T-Cell Responses to Autologous Dendritic/Tumor Vaccines.
    Liu J; Zhang S; Hu Y; Yang Z; Li J; Liu X; Deng L; Wang Y; Zhang X; Jiang T; Lu X
    J Immunother; 2016 May; 39(4):171-80. PubMed ID: 27070448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.